drug interaction(s) of phosphodiesterase-5-inhibitors with alpha-1-adrenergic receptor antagonists

Drug interactions: - risk of orthostatic hypotension may be increased with concurrent administration of alpha-1-adrenergic receptor antagonist & phosphodiesterase-5-inhibitor with alpha-1-adrenergic receptor antagonists

Properties

DRUGS: phosphodiesterase-5 inhibitor alpha-1 adrenergic receptor antagonist

References

Prescriber's Letter 10(9):49,53 2003